HPTN 052 and the future of HIV treatment and prevention

According to WHO guidelines, at least 9 million people worldwide-half again the number of those currently on ARVs-could benefit from being treated. Conversely, those whom society frequently perceives as "innocent" victims-HIV-positive monogamous sex partners or HIV-positive young children-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2011-07, Vol.378 (9787), p.224-225
1. Verfasser:	Cates, Willard
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome AIDS Anti-HIV Agents - administration & dosage Anti-HIV Agents - economics Antiretroviral drugs Behavior Disease transmission Drug resistance Female Health Care Rationing - trends HIV HIV Infections - epidemiology HIV Infections - prevention & control HIV Infections - transmission HIV Seronegativity HIV Seropositivity Human immunodeficiency virus Humans Internal Medicine Male Migrant workers Prevention Primary Prevention - methods Primary Prevention - trends Public health Public Health - trends Randomized Controlled Trials as Topic Reproductive health Risk-Taking Sexual Behavior Sexual Partners Sexually transmitted diseases STD Stereotyping Technological change Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	According to WHO guidelines, at least 9 million people worldwide-half again the number of those currently on ARVs-could benefit from being treated. Conversely, those whom society frequently perceives as "innocent" victims-HIV-positive monogamous sex partners or HIV-positive young children-are not likely to transmit HIV infection to others. [...] under a public health model, these groups become a lower priority for HIV treatment as prevention.
ISSN:	0140-6736 1474-547X
DOI:	10.1016/S0140-6736(11)61116-1